Stephen S - New Jersey Medical School



Stephen S. Kamin, M.D.

Stephen Salaway Kamin

Department of Neurology

Rutgers New Jersey Medical School

90 Bergen St., DOC 8138

Newark, NJ 07103

(973) 972-2557

To make an appointment: (973) 972-2551

1. EDUCATION

a. Undergraduate

9/71–6/75 Harvard College, Cambridge MA

A.B. in Chemistry, summa cum laude

b. Graduate and Professional

9/75–8/80 Department of Chemistry

Graduate School of Arts and Sciences

Harvard University

A.M. in Chemistry

9/80-6/84 Harvard Medical School

Boston, MA

M.D.

2. POSTDOCTORAL TRAINING

a. Internships and Residencies

6/84–6/85 Intern

Department of Medicine

New York Hospital-Cornell Medical Center

New York, NY

7/85–6/88 Resident

Department of Neurology

New York Hospital-Cornell Medical Center

New York, NY

b. Fellowships None

3. MILITARY None

4. LICENSURE

New York #162870 Inactive

New Jersey #25MA05138500 Expiration date 6/30/17

5. CERTIFICATION

11/89 American Board of Psychiatry and Neurology (Neurology)

6. NARCOTICS CERTIFICATION

NJ CDS #D04817300 Expiration date 10/31/16

DEA #BK1424198 Expiration date 12/31/17

7. UNIVERSITY APPOINTMENTS

7/88–6/91 Instructor of Neurosciences

Department of Neurosciences

UMDNJ-New Jersey Medical School

7/91–6/95 Assistant Professor of Neurosciences

Department of Neurosciences

UMDNJ-New Jersey Medical School

7/95–5/98 Associate Professor of Clinical Neurosciences

Department of Neurosciences

UMDNJ-New Jersey Medical School

6/98–Present Associate Professor of Neurosciences

Department of Neurosciences

UMDNJ-New Jersey Medical School

9/04-9/05 Interim Associate Chair for Clinical Activities

Dept. of Neurology & Neurosciences

UMDNJ-New Jersey Medical School

10/05-7/10 Acting Chair

Dept. of Neurology & Neurosciences

UMDNJ-New Jersey Medical School

7/11-10/14 Vice Chair

Dept. of Neurology & Neurosciences

UMDNJ-New Jersey Medical School

11/14-7/14 Interim Chair

Dept. of Neurology

Rutgers New Jersey Medical School

8/15-present Vice Chair

Dept. of Neurology

Rutgers New Jersey Medical School

8. HOSPITAL APPOINTMENTS

7/88–Present Attending Neurologist

University Hospital, Newark, NJ

7/88–Present Attending Neurologist

VA Medical Center, East Orange, NJ

7/90–5/10 Associate Medical Director

Bernard W. Gimbel Multiple Sclerosis Comprehensive Care Center

Holy Name Hospital

Teaneck, NJ

7/11-present Chief of Service

Neurology Service

University Hospital, Newark, NJ

9. OTHER PROFESSIONAL POSITIONS

None

10. AWARDS AND HONORS

6/72 Harvard College Scholarship (Honorary)

6/73 Harvard College Scholarship (Honorary)

5/74 Award for Outstanding Achievement in German

of the German Consulate

6/75 American Institute of Chemists Citation

Outstanding Senior in Chemistry

Harvard College

6/75 Phi Beta Kappa

9/75–8/78 National Science Foundation Graduate Fellow

4/92 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(4th Year Medical School Students)

4/94 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(4th Year Medical School Students)

6/96 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(4th Year Medical School Students)

4/98 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(4th Year Medical School Students)

6/96 Golden Hammer Award (Teaching Award)

Neurology Residents

New Jersey Medical School

6/98 Golden Hammer Award (Teaching Award)

Neurology Residents

New Jersey Medical School

6/99 Golden Hammer Award (Teaching Award)

Neurology Residents

New Jersey Medical School

6/01 Golden Hammer Award (Teaching Award)

Neurology Residents

New Jersey Medical School

5/10 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(3rd Year Medical Students)

6/10 Residency Teaching Award

Neurology Residents

New Jersey Medical School

3/13 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(3rd Year Medical Students)

3/14 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(3rd Year Medical Students)

3/15 Nominated for Golden Apple Award (Teaching Award)

New Jersey Medical School Student Council

(3rd Year Medical Students)

11. BOARD OF DIRECTORS

6/98–1/06 University Physician Associates (Faculty Practice)

2001-2009 Member

By-Laws Committee

University Physicians Associates

2013- Member

Board of Governors

Consortium of Multiple Sclerosis Centers

12. MAJOR COMMITTEE ASSIGNMENTS

a. National and Regional

1993. Member

Professional Advisory Board

Epilepsy Foundation

1996-2008 Member

Consortium of Neurology Program Directors

American Academy of Neurology

1996-2000 Member

Consortium of Neurology Clerkship Directors

American Academy of Neurology

1999-2008 Examiner

Oral Neurology Board Examinations

American Board of Psychiatry and Neurology

2000-2002 Member

Consortium on Physician and Dentist Training in

Health Care to Persons with Developmental Disabilities

(State Governmental Committee)

2000-2005 Member

Scientific Steering Committee, Protectants for Chemical Warfare

Agent-Induced Brain Injury Program

United States Army Medical Research Institute of Chemical Defense

2003-2004 Member

Education Committee

Consortium of Multiple Sclerosis Centers

2003-Present Co-Chair

Therapeutics Research Interest Group

Consortium of Multiple Sclerosis Centers

2006-2013 Member

Research Steering Committee

Consortium of Multiple Sclerosis Centers

2007 Member & Facilitator

Consensus Conference on Treatment of MS Relapses

Consortium of Multiple Sclerosis Centers

2008 Member

Department of Defense Peer Reviewed Medical Research Program

Panel on Multiple Sclerosis

2010 Member

Department of Defense Peer Reviewed Medical Research Program

Panel on Multiple Sclerosis

2011 Member

Department of Defense Peer Reviewed Medical Research Program

Panel on Multiple Sclerosis

2013- Chair

Research Committee

Consortium of Multiple Sclerosis Centers

2013- Member

Board of Governors

Consortium of Multiple Sclerosis Centers

b. Medical School

1993–2000 Member

Clinical Curriculum Subcommittee

UMDNJ-New Jersey Medical School

Newark, NJ

1993–2008 Member

Graduate Medical Education Committee

UMDNJ-New Jersey Medical School

Newark, NJ

1997–1998 Vice-Chairman

Clinical Curriculum Subcommittee

UMDNJ-New Jersey Medical School

Newark, NJ

1998. Member

Continuing Medical Education Committee

UMDNJ-New Jersey Medical School

Newark, NJ

1999-2001 Member

Committee on Academic Policies and Procedures

UMDNJ-New Jersey Medical School

2005-2010, Member

2014- Faculty Council

UMDNJ-New Jersey Medical School

2010-present Member

Pre-Clinical Curriculum Committee

UMDNJ-New Jersey Medical School

2011-2012 Member

Student Affairs Committee

UMDNJ-New Jersey Medical School

2011-2012 Member

Integrated Faculty Practice task force

2013- Group Leader

Curriculum Renewal task force

c. Hospital

2002-2004 Member

Reimbursement Committee

NJ Med, P.C.

2005-2010 Member

2011-Present Chief of Services Committee

University Hospital

2005-2010 Member

2011-Present Medical Executive Committee

UMDNJ-New Jersey Medical School

2010-2015 Member

Clinical Practice Committee

University Hospital

d. Department

1999-2008 Chairman, Residency Review Committee

2011- Member

Committee on Appointments and Promotions

e. Editorial Boards None

1993–Present Ad hoc reviewer, Neurology

1998–Present Ad hoc reviewer, Journal of Neurology, Neurosurgery and Psychiatry

13. MEMBERSHIPS

1975-2011 American Association for the Advancement of Science

2000-2010 Association of University Professors of Neurology

2008-2010 Association of Medical School Neuroscience Department Chairs

2000-Present American Association of University Professors

14. RESEARCH INTERESTS

Multiple Sclerosis, Cerebrovascular Disease

1989–1994 Participating neurologist, “ACAS” Study of Endarterectomy in Asymptomatic Carotid Stenosis

1996-1998 Co-Investigator, "ICOS" Study of monoclonal antibody in treatment of acute relapses in multiple sclerosis

2001. Co-Investigator "MSTrac" Multiple sclerosis treatment database

1999-2001 Co-Investigator, "CORAL" Study of Oral Copaxone in relapsing-

remitting multiple sclerosis

1999-2001 Co-Investigator, “EVIDENCE” trial (Comparison of Rebif and Avonex in treatment of newly diagnosed multiple sclerosis)

1999-2003 Principal investigator, “ProMiSE” trial (Copaxone in treatment of primary progressive multiple sclerosis)

2003-2009 Co-Investigator, “BECOME” trial (Comparison of Betaseron and Copaxone in treatment of multiple sclerosis)

2003-2005 Consultant, Effect of cognitive Deficits on Driving in Patients with Multiple Sclerosis, Kessler Institute for Rehabilitation

2003- Principal Investigator, “ABOVE” trial (Comparison of Avonex and Betaseron in treatment of multiple sclerosis)

2003- Co-investigator, “BEYOND” trial (Comparison of Betaseron and Copaxone in treatment of newly diagnosed multiple sclerosis)

2003- Principal investigator, “ACHIEVE” study (Comparison of Copaxone and high-dose interferon in multiple sclerosis patients failing treatment with interferons)

2007- Principal investigator, “ONWARD” study (Comparison of Rebif to Rebif plus cladribine in multiple sclerosis patients)

2008- Principal investigator, “CARE-MS” study (Comparison of Alemtuzumab and Rebif in multiple sclerosis patients)

2008- Principal investigator, “TYGRIS” Study (Phase IV study of Tysabri use and safety)

2008- Principal neurology investigator, “SAMMPRIS” (Comparison of intensive medical therapy and stenting in patients with recent stroke)

2008- Co-investigator, CLARITY trial (Oral cladribine in multiple sclerosis)

2009- Co-investigator, PFO ACCESS Registry Trial (Registry of use of PFO closure device to prevent stroke)

2009-2013 Co-investigator, RESPECT Trial (PFO closure in recurrent stroke)

2010- Principal investigator, AC-058B201 (Efficacy and safety of ACT-128800 in the treatment of multiple sclerosis)

2010- Co-investigator, SURPASS Trial (Benefits of switching to Tysabri in multiple sclerosis)

2010- Principal investigator, PREMIERE Trial (Observational study of safety of oral cladribine in multiple sclerosis)

2011 Principal investigator, STRATIFY Trial (Assessment of JCV antibody status in patients on Tysabri)

2012- Co-investigator, OPERA Trial (Ocrelizumab in multiple sclerosis)

2012-2015 Principal investigator, ASCEND Trial (Natalizumab in secondary progressive multiple sclerosis)

2013-2015 Principal investigator, ASSESS Trial (High dose vs. low dose fingolimod in multiple sclerosis)

2015- Principal investigator, ESTEEM Trial (Real-life observational study of dimethyl fumarate)

2015- Principal investigator, PASSAGE Trial (Safety study of fingolimod)

15. GRANTS

1999-2003 Principal Investigator, “PROMISE” Trial of Glatiramer acetate in primary progressive multiple sclerosis

2001-2003 Principal Investigator, A Phase II, Randomized, Double-Blind Placebo Controlled Study to Evaluate the Preliminary Efficacy, Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects with Relapsing-Remitting Multiple Sclerosis

2007- Principal investigator, “ONWARD” study (Comparison of Rebif to Rebif plus cladribine in multiple sclerosis patients)

2008- Principal Investigator, “CARE-MS” Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis

2010- Principal investigator, AC-058B201 (Efficacy and safety of ACT-128800 in the treatment of multiple sclerosis)

2010- Principal investigator, PREMIERE Trial (Observational study of safety of oral cladribine in multiple sclerosis)

2011 Principal investigator, STRATIFY Trial (Assessment of JCV antibody status in patients on Tysabri)

2012- Principal investigator, ASCEND Trial (Natalizumab in secondary progressive multiple sclerosis)

2013- Principal investigator, ASSESS Trial (High dose vs. low dose fingolimod in multiple sclerosis)

2015- Principal investigator, ESTEEM Trial (Observational study on

dimethyl fumarate)

2015- Principal investigator, PASSAGE Trial (Fingolimod safety study)

16. MAJOR TEACHING EXPERIENCE

Harvard University

6/75–8/75 Teaching Fellow

Chemistry S-20 (Organic Chemistry)

Harvard Summer School, Cambridge, MA

2/76–6/76 Teaching Fellow

Chemistry 20b (Organic Chemistry)

Harvard University, Cambridge, MA

9/76–6/80 Resident Tutor in Chemistry

Quincy House

Harvard University, Cambridge, MA

2/78-6/78 Teaching Fellow

Chemistry 20b (Organic Chemistry)

Harvard University, Cambridge, MA

6/80–8/80 Head Teaching Fellow

Chemistry S-20 (Organic Chemistry)

Harvard Summer School, Cambridge, MA

9/80–6/84 Pre-Medical Advisor

Quincy House

Harvard University, Cambridge, MA

6/81–8/81 Head Teaching Fellow

Chemistry S-20 (Organic Chemistry)

Harvard Summer School, Cambridge, MA

2/84–3/84 Instructor, “Introduction to Clinical Medicine”

(Physical Diagnosis)

Harvard Medical School and Massachusetts General Hospital

Boston, MA

UMDNJ-New Jersey Medical School

1993. Program Co-Chairperson

Seminar

“Stroke Treatment: Current Practice and New Developments”

UMDNJ-New Jersey Medical School

1995-2005 Lecturer & Clinical Component Coordinator

Neurosciences I (1st year course)

1995-2005 Lecturer & Coordinator

Introduction to Clinical Medicine, Neurology Section

1999–Present Resident Lecture Series

1999-2002 Lecturer

Pathophysiology Course, Neurology section

Physical Therapy Program

1999-Present Lecturer

Intensive Review of Medicine (4th year course)

2006-2010 Lecturer & Clinical Component Coordinator

Mind, Brain and Behavior (1st year course)

2006-present Lecturer

Disease Process, Prevention and Therapy (2nd year course)

2009-present Coordinator

Physician’s Core 2, Neurology component

2010-present Course Co- Director (with Barbara Fadem, Dept. of Psychiatry)

Mind, Brain and Behavior

UMDNJ-Gradual School of Biological Sciences

2011-present Lecturer

Behavioral and Cognitive Neurosciences

2012-present Lecturer

Neurobiology of Disease

VA Medical Center

7/88-3/99 Neurology Morning Report

Resident Lecture Series

Neurology-Neurosurgery Conference

Neurology-Vascular Surgery Conference

Neuroradiology Conference

Chief-of-Service Rounds

4/99-2004 Resident Lecture Series

Outside Lectures

5/91 Invited speaker

“New Treatments in Cerebrovascular Disease”

A Roving Symposium

Runnells Specialized Hospital, Berkeley Heights, NJ

10/93 Grand Rounds

“Current Concepts of Management and Prevention of Stroke”

United Hospitals Medical Center, Newark, NJ

11/93 Invited speaker

“New Treatments in Cerebrovascular Disease”

A Roving Symposium

St. Mary’s Hospital, Passaic, NJ

10/94 Invited speaker

“Update on Multiple Sclerosis.”

General Hospital Center at Passaic, NJ

11/95 Invited speaker

“New Treatments in Cerebrovascular Disease”

East Orange General Hospital, East Orange, NJ

5/95 Faculty Member

“Multiple Sclerosis: Advances in Clinical Management”

5/9/95 Hartford, CT

5/11/95 Uniondale, NY

5/23/95 East Rutherford, NJ

3/96 Faculty Member

Temple University 20th Annual Family

Practice Review, “Multiple Sclerosis Workshop”

Lancaster, PA

5/96 Invited speaker

“Parkinson’s Disease and Parkinsonism”

Greystone Park Psychiatric Hospital, Morristown, NJ

5/96 Invited speaker

“Treatment of Stroke”

St. Elizabeth Hospital, Elizabeth, NJ

1/98 Invited speaker

“Peripheral Neuropathy in General Medicine”

St. Mary’s Hospital, Passaic, NJ

2/02 Invited speaker

“Current Management of Multiple Sclerosis”

Our Lady of Lourdes Medical Center

Camden, NJ

4/05 Invited Speaker

“Neurofibromatosis”

Holy Name Hospital

Teaneck, NJ

9/05 Invited speaker

“Current Management of Multiple Sclerosis”

Newark Beth Israel Medical Center

Newark, NJ

6/06 Faculty member

“Choosing the Right Therapy at the Right Time”

Symposium on multiple sclerosis treatment

Consortium of Multiple Sclerosis Centers Annual Meeting

6/07 Faculty member

“Treatment of Breakthrough Disease”

Symposium on multiple sclerosis treatment

Consortium of Multiple Sclerosis Centers Annual Meeting

5/08 Invited speaker

“Basics of the Neurological Examination”

“Red Flags in the Neurological Examination”

Consortium of Multiple Sclerosis Centers Annual Meeting

6/09 Invited speaker

“Basics of the Neurological Examination”

Consortium of Multiple Sclerosis Centers Annual Meeting

6/10 Invited speaker

“How to do the EDSS”

Consortium of Multiple Sclerosis Centers Annual Meeting

6/10 Invited speaker

“MRI and Multiple Sclerosis”

Novartis Preceptorship in MS

9/10 Invited Speaker

“Pharmacological Interventions for Cognition in MS”

Consensus Conference, Translating What We Know about Assessment and Intervention for Cognitive Problems into Practical Applications in

the Neurology Clinic, Consortium of Multiple Sclerosis Centers

12/10 Invited speaker

“New and Emerging Therapies in MS”

Panel on Patient Decision-making and the Team Approach to New

and Emerging Therapies, Consortium of Multiple Sclerosis

Centers

6/11 Invited speaker

“How to do the EDSS”

Consortium of Multiple Sclerosis Centers Annual Meeting

8/11 Invited speaker

“New and Emerging Therapies in MS”

Ellis Hospital, Schenectady, NY

6/12 Invited speaker

“Diagnosis of MS: The Neurological Examination:

Consortium of Multiple Sclerosis Centers Annual Meeting

2/13 Invited speaker

“Unusual Causes of Myelopathy”

Grand Rounds, Department of Neurology

Robert Wood Johnson Medical School

5/13 Invited speaker

“Disease Modifying Agents in MS: The Pivotal Trials”

Consensus Conference, Best Practices in the Selection of Disease Modifying Agents in Multiple Sclerosis, Consortium of MS Centers

6/13 Invited speaker

“How to do the EDSS”

Consortium of Multiple Sclerosis Centers Annual Meeting

5/14 Invited speaker

“How to do the EDSS”

Consortium of Multiple Sclerosis Centers Annual Meeting

6/14 Invited speaker

“Current Diagnosis and Treatment of Multiple Sclerosis”

Grand Rounds, Dept. of Medicine

St. Joseph’s Medical Center, Paterson NJ

10/14 Invited speaker

“Multiple Sclerosis and its Mimics

Grand Rounds, Dept. of Medicine

Trinitas Medical Center, Elizabeth NJ

9/15 Invited speaker

“Multiple Sclerosis and its Mimics

Grand Rounds, Dept. of Medicine

Queens Hospital Center, Queens, NY

10/15 Invited speaker

“Therapeutic Decision Making in Multiple Sclerosis”

Web-based CME

Consortium of Multiple Sclerosis Centers

4/16 Invited speaker

“Aphasia”

Grand Rounds, Dept. of Medicine

Trinitas Medical Center, Elizabeth NJ

6/16 Invited speaker

“How to do the EDSS”

Consortium of Multiple Sclerosis Centers Annual Meeting

17. PRINCIPAL CLINICAL RESPONSIBILITIES

1998. Attending Neurologist

VA Medical Center

East Orange, NJ

1988-Present Attending Neurologist

University Hospital

Newark, NJ

1989-2009 Neurologist

Bernard Gimbel Multiple Sclerosis Comprehensive Care Center

Teaneck, NJ

1994-Present Neurologist

Neurofibromatosis Center

UMDNJ-New Jersey Medical School, Newark, NJ

18. ADMINISTRATIVE RESPONSIBILITIES

1988-2008 Director of the Neurology Residency Training Program with primary responsibility for organization of the program, teaching of residents and evaluation of residency applicants

1991-2000 Coordinator, Fourth Year Student Rotation in Neurology,

UMDNJ-New Jersey Medical School. Responsible for organization of mandatory clerkship and evaluation of students

1994-2005 Coordinator, Neurology Section of Introduction to Clinical Science

(2nd year pathophysiology course)

2004-2005 Interim Associate Chair for Clinical Activities

Dept. of Neurology & Neurosciences

2005-2010 Acting Chair

Dept. of Neurology & Neurosciences

2010-present Course Co-Director

Mind, Brain & Behavior

2011-2014 Vice Chair

Dept. of Neurology & Neurosciences

2014-2015 Interim Chair

Dept. of Neurology

19. PRIVATE PRACTICE

1988-Present University Physicians Associates

20. ARTICLES

Bunn, H.F., Haney, D.N., Kamin, S.S., Gabbay, K.H. and Gallop, P.M., “The biosynthesis of human hemoglobin Alc.” J. Clin. Invest. (1976) 57: 1652-1659.

Kamin, S.S., and Petito, C.K., “Idiopathic myelopathies with white matter vacuolation in non-AIDS patients.” Human Path (1991) 22: 816-824

Deutsch. A., Levin, B., Nathanson, D. and Kamin, S.S., “Temporary reversal of cord compression with hyperosmolar glucose.” Neurology (1992) 42: 222

Kamin, SS., “Is computed tomography-negative intracerebral hemorrhage really negative?” [Letter], Arch Neurology (2004) 61: 801

Souayah, N., Karim, H., Kamin, S., McArdle, J. and Marcus, S. “Severe botulism after focal injection of botulinum toxin.” Neurology (2006) 67:1855-6

Charles, J, Kamin, SS, Weisholtz, S, Fontana, L, et al. “Enterococcus faecalis Brain Abscess Related to Piperacillin /Tazobactam with the Radiographic Appearance of a Neoplasm; Case Report”, Infections in Medicine (2007) 24: 177-179

Cadavid, D, Wolansky, LJ, Skurnick, J, Lincoln, J, Cheriyan, J, Szczepanowski, K,

Kamin, SS, Pachner, AR, Halper, J, Cook, SD. “Efficacy of treatment of MS with IFN[beta]-1b or glatiramer acetate by monthly brain MRI in the BECOME study” Neurology (2009) 72: 1976-1983

Ford, C et al. “Therapeutic Decision-Making in Multiple Sclerosis”, Int J MS Care (2014) 16: Suppl. 1

21. BOOKS

Kamin, S.S., “Vascular, Nutritional and Other Diseases of the Spinal Cord”, in Kirshblum, S., Campagnolo, D.I. & DeLisa, J.A., Spinal Cord Medicine (2002), 513-526,

Lippincott, Williams & Wilkins, Philadelphia

Kamin, S.S., “Vascular, Nutritional and Other Nontraumatic Conditions of the Spinal Cord”, in Kirshblum, S., Campagnolo, D.I. & DeLisa, J.A., Spinal Cord Medicine, 2nd edition (2011), 600-616, Lippincott, Williams & Wilkins, Philadelphia

22. ABSTRACTS

Kamin, S.S., and Petito, C.K., “Vacuolar myelopathy in immunocompromised non-AIDS patients.” J. Neuropathol. Exp. Neurol. (1988) 47: 385.

Pletcher, B.A., Magee, M.L., Frohman, L.P., Wagner, R.S., DeRespinis, P.,

Kamin, S.S., and Chatkupt, S. “Confirmation of decreased risk of optic glioma in African-Americans with NF type 1.” American Society of Human Genetics, 1996.

Morgan, J.E., Lynch, J.K., and Kamin, S.S., “The fate of intellect and memory over time in Alcoholic Korsakoff’s Syndrome: A case of an eleven month test re-test interval. Arch. Clin. Neuropsych. (1997) 12: 32.

Morgan, J.E., Weinberger, L., Kamin, S.S., and Johnson, B-A. “The neuropsychology of the Right Frontal Syndrome: a striking constellation of deficits and preserved functions.” 17th Annual Conference of the National Academy of Neuropsychology, Nov. 1997.

Morgan, J.E., DaSilva, D., Kamin, S.S., and Lynch, J.K. “Severe apperceptive visual agnosia in left unilateral pathology: an unusual deficit in the absence of bilateral brain disease. Arch. Clin. Neuropsych. (1997) 13: 120.

Morgan, J.E., Lynch, J.K. and Kamin, S.S. “Severe constructional dyspraxia in a CVA

of the dominant hemisphere: marked visuo-constructive deficits in the absence of

non-dominant hemisphere pathology.” Arch. Clin. Neuropsych. (1997) 12: 371.

Morgan, J.E., Kamin, S.S., Majmundar, N. and Johnson, B-A. “Severe Frontal syndrome of the “Bilateral Type” in a left Unilateral Frontal Infarct.” 18th Annual Meeting of the National Academy of Neuropsychology, Nov. 1998.

Souayah, N., Karim, H., Kamin, S., McArdle, J., Marcus, S. “Severe Botulism after Focal Injection of Botulinum Toxin”. American Association of Neuromuscular and Electrodiagnostic Medicine annual meeting, 2005

Wolansky L., Cadavid D., Cook S., Pachner A., Kamin S.,. Jotkowitz S, Hill J., Skurnick J., Tulloch K.,. Younes M, Liu W., Biswal B.,. Turbin R,. Frohman L. Comparing interferon beta-1b and glatiramer acetate: patient baseline characteristics from the Betaferon(r)/Betaseron(r) versus Copaxone(r) in MS patients using triple-dose gadolinium and 3-Tesla MRI Endpoints (BECOME) study. 10th ACTRIMS/21st ECTRIMS, Greece, October 2005.

Cadavid D., Wolansky L., Cook S., Pachner A., Kamin S., Jotkowitz S., Hill J., Skurnick J., Tulloch K.,. Younes M, Biswal B., Turbin R.,. Frohman L, Liu W., Haghighi M. Comparing interferon beta-1b and glatiramer acetate: the BECOME (BEtaferon/Betaseron versus COpaxone in MS patients using triple-dose gadolinium and 3-Tesla MRI Endpoints) study. 10th ACTRIMS/21st ECTRIMS, Tessalonika, Greece, October 2005.

McArdle, J., Karim, H, Kamin, S., Marcus, S, and Souayah, N. “Therapy, survival and long-term recovery following severe poisoning with botulinum toxin A”. Army Medical Research Institute of Chemical Defense Bioscience Review 2006

Cook, SD, Khaitov D, Kamin, S. “A Critical Analysis of Assessment Tools for Disability.” European Charcot Foundation, Marbella, Spain, November 2012

23. REVIEWS

Kamin, S. S. & Garstang, S. “Vascular Disease of the Spinal Cord”. Topics Spinal Cord Inj Rehab (2008) 14: 42-53

24. REPORTS None

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download